Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
2001 1
2004 2
2005 1
2008 1
2010 2
2011 1
2014 3
2016 1
2017 4
2018 2
2020 7
2021 9
2022 5
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Gurminderjeet
Page 1
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial.
Birtle A, Johnson M, Chester J, Jones R, Dolling D, Bryan RT, Harris C, Winterbottom A, Blacker A, Catto JWF, Chakraborti P, Donovan JL, Elliott PA, French A, Jagdev S, Jenkins B, Keeley FX Jr, Kockelbergh R, Powles T, Wagstaff J, Wilson C, Todd R, Lewis R, Hall E. Birtle A, et al. Lancet. 2020 Apr 18;395(10232):1268-1277. doi: 10.1016/S0140-6736(20)30415-3. Epub 2020 Mar 5. Lancet. 2020. PMID: 32145825 Free PMC article. Clinical Trial.
Cheyne-stokes respiration in children with heart failure.
Singh J, Zaballa K, Kok H, Fitzgerald N, Uy C, Nuth D, Castro C, Irving C, Waters K, Fitzgerald DA. Singh J, et al. Paediatr Respir Rev. 2022 Sep;43:78-84. doi: 10.1016/j.prrv.2022.03.001. Epub 2022 Mar 8. Paediatr Respir Rev. 2022. PMID: 35459626 Review.
Transition to adult care in cystic fibrosis: The challenges and the structure.
Singh J, Towns S, Jayasuriya G, Hunt S, Simonds S, Boyton C, Middleton A, Kench A, Pandit C, Keatley LR, Chien J, Bishop J, Song Y, Robinson P, Selvadurai H, Middleton PG, Fitzgerald DA. Singh J, et al. Paediatr Respir Rev. 2022 Mar;41:23-29. doi: 10.1016/j.prrv.2020.07.009. Epub 2020 Aug 2. Paediatr Respir Rev. 2022. PMID: 32917516 Review.
Urinothorax following percutaneous image-guided renal cryoablation.
Ng H, Wang K, Cartledge J, Biyani CS, Ralph C, Jagdev S, Vasudev N, Bhattarai S, Bhartia B, Lenton J, Smith J, Whiteley S, Tcherveniakov P, Wah TM. Ng H, et al. Radiol Case Rep. 2020 Sep 15;15(11):2348-2352. doi: 10.1016/j.radcr.2020.09.013. eCollection 2020 Nov. Radiol Case Rep. 2020. PMID: 32994839 Free PMC article.
A systematic review on the use of bacteriophage in treating Staphylococcus aureus and Pseudomonas aeruginosa infections in cystic fibrosis.
Singh J, Yeoh E, Fitzgerald DA, Selvadurai H. Singh J, et al. Paediatr Respir Rev. 2023 Dec;48:3-9. doi: 10.1016/j.prrv.2023.08.001. Epub 2023 Aug 11. Paediatr Respir Rev. 2023. PMID: 37598024 Review.
This systematic review evaluates the safety and effectiveness of bacteriophages for the treatment of CF-related infections caused by S. aureus and/or P. aeruginosa. We conducted a search for original, published articles in the English language up to March 2023. ...Evidence …
This systematic review evaluates the safety and effectiveness of bacteriophages for the treatment of CF-related infections caused by S …
Single-arm, open-labelled, safety and tolerability of intrabronchial and nebulised bacteriophage treatment in children with cystic fibrosis and Pseudomonas aeruginosa.
Singh J, Fitzgerald DA, Jaffe A, Hunt S, Barr JJ, Iredell J, Selvadurai H. Singh J, et al. BMJ Open Respir Res. 2023 May;10(1):e001360. doi: 10.1136/bmjresp-2022-001360. BMJ Open Respir Res. 2023. PMID: 37160359 Free PMC article.
Safety and tolerability will be defined as the absence of (1) fever above 38.5C occurring within 1 hour of the administration of the nebulised bacteriophage, (2) a 10% decline in spirometry (forced expiratory volume in 1 s %) measured preadministration and postadministrati …
Safety and tolerability will be defined as the absence of (1) fever above 38.5C occurring within 1 hour of the administration of the nebulis …
39 results